Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 9,933 | 13,544 | 49,459 | 29,222 | 26,488 |
| Cost of Goods | 2,711 | 3,266 | 13,654 | 10,677 | 7,786 |
| Gross Profit | 7,222 | 10,278 | 35,805 | 18,545 | 18,702 |
| Operating Expenses | 26,403 | 22,290 | 24,981 | 27,257 | 32,721 |
| Operating Income | -18,470 | -11,746 | 11,478 | -8,035 | -13,233 |
| Interest Expense | 775 | 772 | 770 | 768 | 765 |
| Other Income | 434 | 772 | 690 | -7,493 | 702 |
| Pre-tax Income | -18,811 | -11,746 | 11,398 | -16,296 | -13,296 |
| Income Tax | 45 | 181 | -47 | 56 | 245 |
| Net Income Continuous | -18,856 | -11,927 | 11,445 | -16,352 | -13,541 |
| Net Income | $-18,856 | $-11,927 | $11,445 | $-16,352 | $-13,541 |
| EPS Basic Total Ops | -2.93 | -1.87 | 1.80 | -2.55 | -2.12 |
| EPS Basic Continuous Ops | -2.93 | -1.85 | 1.78 | -2.55 | -2.12 |
| EPS Diluted Total Ops | -2.93 | -1.72 | 1.65 | -2.55 | -2.12 |
| EPS Diluted Continuous Ops | -2.93 | -1.68 | 1.61 | -2.55 | -2.12 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.86 | 1.65 | -2.55 | -2.10 |
| EBITDA(a) | $-12,505 | $-5,829 | $17,272 | $1,350 | $-3,849 |